Pediatric Interventional Cardiology Market (by Congenital Heart Defect Closure Device, Procedures) worth $1,379.1 …

Posted: Published on April 15th, 2014

This post was added by Dr P. Richardson

(PRWEB) April 15, 2014

The Pediatric Interventional Cardiology Market by Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures - Global Forecasts to 2018 analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, APAC, and the Rest of the World.

Browse more than 90 market data tables with 19 figures spread through 165 pages and in-depth TOC on "Pediatric Interventional Cardiology Market"

http://www.marketsandmarkets.com/Market-Reports/pediatric-interventional-cardiology-market-236831456.html

Early buyers will receive 10% customization on this report.

This report studies the global pediatric interventional cardiology market over the forecast period of 2013 to 2018. This market is valued at an estimated $894.7 million in 2013 and is poised to grow at a CAGR of 9.0% from 2013 to 2018.

Ask for Free Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=236831456.

Various new procedures and interventional devices are being developed and launched in the market, which is a major reason for the rapid growth of this market. Companies are heavily investing in R&D, to develop new and advanced devices that cater to the unmet needs of pediatric patients. Furthermore, the high growth potential of the transcatheter heart valves market is another factor that is propelling the growth of this market. Based on device type, the ASD, VSD, and PFO devices market accounted for the largest share of 28% in 2013. However, the transcatheter pulmonary valve market is poised to grow at the highest CAGR from 2013 to 2018.

The market is expected to witness a healthy growth in the forecast period. This high growth can be attributed to a number of factors such as the rising incidences of congenital heart disease and FDAs initiatives to seep-up the regulatory procedure. Technological advancements, owing to which new and advanced products are being launched in the market, is another factor propelling the growth of this market. The untapped markets in the Asia-Pacific region are major opportunity areas for pediatric interventional cardiology companies. Limited penetration of cardiac devices which are specifically designed for pediatric patients is a major unmet need in this market; it offers a huge array of opportunities for the market to grow. However, varied stringency of regulatory procedures across the globe and the presence of complex regulatory procedures may hinder the growth of this market.

Inquire Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=236831456.

See the article here:
Pediatric Interventional Cardiology Market (by Congenital Heart Defect Closure Device, Procedures) worth $1,379.1 ...

Related Posts
This entry was posted in Cardiology. Bookmark the permalink.

Comments are closed.